Actemra, Long-Term Special Drug Use Surveillance in Takayasu arteritis and Giant cell arteritis patients
Latest Information Update: 11 Jan 2022
At a glance
- Drugs Tocilizumab (Primary)
- Indications Arteritis; Giant cell arteritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 07 Jan 2022 Status changed from not yet recruiting to completed.
- 15 Sep 2017 New trial record